RecruitingNCT05958901

Pulmonary Hypertension Observational Study

A Observational Study in Chinese Patients With Pulmonary Hypertension (PH)


Sponsor

The First Affiliated Hospital of Guangzhou Medical University

Enrollment

10,000 participants

Start Date

Jul 12, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to establish the large PH cohort and biological database in China, aiming for precision medicine to optimize diagnosis and treatment choices.


Eligibility

Min Age: 20 YearsMax Age: 70 Years

Inclusion Criteria2

  • PH group: When the mean pulmonary artery pressure is greater than 25mmHg at rest or greater than 30mmHg during exercise.
  • Signed informed consent obtained prior to participations with the ability to comply with protocol and be available for study visits over 5 years.

Exclusion Criteria7

  • Acute exacerbation in the past 3 months Having other respiratory diseases with massive lung tissue destruction such as severe bronchiectasis and tuberculosis, etc.
  • Serious uncontrolled diseases thoracic or abdominal surgery in the last 3 months.
  • Eye surgery in the last three months.
  • Retinal detachment myocardial infarction in the last 3 months.
  • Admission to hospital for any cardiac condition in the last month.
  • Heart rate over 120 beats per minute.
  • Antibacterial chemotherapy for tuberculosis pregnant or breast feeding.

Interventions

OTHERpulmonary hypertension

The final outcome observed was a diagnosis of pulmonary hypertension.


Locations(1)

The First Affiliated Hospital of Guangzhou Medical University

Guangzhou, Guangdong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05958901


Related Trials